| Literature DB >> 19290041 |
Giovanni Cattoli1, Isabella Monne, Alice Fusaro, Tony M Joannis, Lami H Lombin, Mona M Aly, Abdel S Arafa, Katharine M Sturm-Ramirez, Emmanuel Couacy-Hymann, Joseph A Awuni, Komla B Batawui, Kodzo A Awoume, Gilbert L Aplogan, Adama Sow, Andrè C Ngangnou, Iman M El Nasri Hamza, Djibo Gamatié, Gwenaelle Dauphin, Joseph M Domenech, Ilaria Capua.
Abstract
Highly pathogenic avian influenza virus A/H5N1 was first officially reported in Africa in early 2006. Since the first outbreak in Nigeria, this virus spread rapidly to other African countries. From its emergence to early 2008, 11 African countries experienced A/H5N1 outbreaks in poultry and human cases were also reported in three of these countries. At present, little is known of the epidemiology and molecular evolution of A/H5N1 viruses in Africa. We have generated 494 full gene sequences from 67 African isolates and applied molecular analysis tools to a total of 1,152 A/H5N1 sequences obtained from viruses isolated in Africa, Europe and the Middle East between 2006 and early 2008. Detailed phylogenetic analyses of the 8 gene viral segments confirmed that 3 distinct sublineages were introduced, which have persisted and spread across the continent over this 2-year period. Additionally, our molecular epidemiological studies highlighted the association between genetic clustering and area of origin in a majority of cases. Molecular signatures unique to strains isolated in selected areas also gave us a clearer picture of the spread of A/H5N1 viruses across the continent. Mutations described as typical of human influenza viruses in the genes coding for internal proteins or associated with host adaptation and increased resistance to antiviral drugs have also been detected in the genes coding for transmembrane proteins. These findings raise concern for the possible human health risk presented by viruses with these genetic properties and highlight the need for increased efforts to monitor the evolution of A/H5N1 viruses across the African continent. They further stress how imperative it is to implement sustainable control strategies to improve animal and public health at a global level.Entities:
Mesh:
Year: 2009 PMID: 19290041 PMCID: PMC2653644 DOI: 10.1371/journal.pone.0004842
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Bayesian trees for the HA (left) and NA (right) gene of A/H5N1 representative strains from Africa, Europe and Middle East (clade 2.2).
Different colours are used to differentiate the viruses from distinct sublineages. Posterior probabilities are indicated above branches. Scale bar represents the number of substitutions per site. The map highlights the countries where influenza viruses were isolated. The colours of the map are the same adopted in the phylogenetic trees indicating the sublineages of clade 2.2.
Typical amino acid signature of human influenza viruses observed in the African strains.
| Protein | aa position | Predicted aa | Reference | Strains | Mutation | |
| Avian | Human | |||||
| 661 | A | T |
| A/ck/Ghana/2534/07 | A661T | |
| PB2 |
| |||||
| 199 | A | S |
| A/ck/Egypt/5169-5/07; A/dk/Egypt/5169-6/07 | A199S | |
| 627 | E | K |
| All strains analysed in this study | E627K | |
| 73 | K | R |
| All strains analysed in this study belonging to IV sublineage | K73E | |
| A/dk/Egypt/452-1/06; A/ck/Egypt/452-2/07 | ||||||
| PB1-F2 | 82 | L | S |
| A/dk/Egypt/5169-1/07; A/dk/Egypt/5169-4/07 | L82S |
| A/ck/Egypt/5169-5/07; A/Egypt/902786/06 | ||||||
| 79 | R | Q |
| A/ck/Egypt/5169-3/07 | R79Q | |
| A/ck/Nigeria/1071-3/07; A/ck/Nigeria/1071-7/07 | ||||||
| PA | 100 | V | A |
| A/ck/Nigeria/AB13/06; A/ck/Nigeria/AB14/06 | V100A |
| 400 | Q/T/S | L |
| A/dk/Egypt/1709-3VIR08/07; A/ck/Egypt/2628-2/07 | S400L | |
| 356 | K | R |
| A/ck/Burkina Faso/1347-16/06 | K356R | |
|
| ||||||
| NP | 33 | V | I |
| 78/81 viruses | V33I |
| A/ck/Egypt/5169-2/07; A/ck/Egypt/5169-3/07 | ||||||
| 109 | I | V |
| A/ck/Nigeria/1047-8/06 | I109V | |
| A/ck/Sudan/1784-8/06; A/ck/Sudan/1784-7/06 | ||||||
| M2 | 55 | L | F |
| A/ck/Sudan/1784-10/06; A/ck/Sudan/2115-9/06 | L55F |
| A/ck/Sudan/2115-12/06; A/ck/Sudan/2115-10/06 | ||||||
| A/hooded vulture/BurkinaFaso/2/06 | ||||||
|
| ||||||
| NS1 | 227 | E | R o K (H1N1) |
| A/ck/Nigeria/FA4/06; A/ck/Nigeria/FA7/06 | E227G |
| NS2 | 70 | S | G |
| A/ck/Nigeria/FA4/06; A/ck/Nigeria/FA7/06 | S70G |
Substitutions that can alter the sensitivity of A/H5N1 African viruses to antiviral drugs.
| Susceptibility of avian influenza viruses to neuraminidase inhibitors | |||||
| Position | Residue in NA | Substitution associated with resistance | Reference | Strains | Mutation |
| 294 | N | S |
| A/Egypt/14725-NAMRU3/06 | N294S |
| A/Egypt/14724-NAMRU3/06 | |||||
N2 numbering.
Substitutions in the HA glycoprotein of African A/H5N1 viruses.
| Virus strains | Position | Mutations at RBS or adjacent to it |
| A/Egypt/0636-NAMRU3/2007; A/Egypt/1394-NAMRU3/07; A/Egypt/2621-NAMRU3/2007 | 133 | Deletion |
| A/Egypt/2629-NAMRU3/2007; A/Egypt/2631-NAMRU3/2007; A/ck/Egypt/R2/07; A/ck/Egypt/R3/07 | ||
| A/ck/Egypt/R4/07; A/ck/Egypt/R5/07; A/ck/Egypt/R6/07; A/ck/Egypt/9400NAMRU3-CLEVB211/07 | 155 | I155T |
| A/chicken/Nigeria/1071-10/2007; A/chicken/Nigeria/1071-22/2007; | ||
| A/chicken/Egypt/3044NAMRU3-CLEVB59/2007; A/chicken/Egypt/3045NAMRU3-CLEVB60/2007 | 133 | S133L |
| A/chicken/Egypt/3046NAMRU3-CLEVB62/2007; A/crow/Egypt/9382NAMRU3-CLEVB111/2007 | ||
| A/chicken/Egypt/9383NAMRU3-CLEVB112/2007; A/chicken/Egypt/9384NAMRU3-CLEVB118/2007 | ||
| A/dk/Egypt/5169-1/07 | 186 | N186S |
| A/Egypt/2947-NAMRU3/06 | 227 | S227N |
| 32 Egyptian strains | 230 | M230I |
| 11 Egyptian strains | 230 | M230V |
H3 numbering.
H5 numbering.
Unique amino acid changes in the HA protein identified in A/H5N1 viruses circulating in a given country or geographical area.
| Country | aa substitution | No. HA sequences | No. HA sequences with characteristic substitution |
| Sudan | R341G | 6 | 6 |
| Egypt | 142 Egypt | 141 Egypt | |
| Djibouti | P251S | 1 Djibouti | 1 Djibouti |
| Ghana | 4 Ghana | 4 Ghana | |
| Ivory Coast | S16G | 7 Ivory Coast | 7 Ivory Coast |
| Burkina Faso | 10 Burkina Faso | 10 Burkina Faso | |
| Togo | T175I | 3 | 3 |
except for A/teal/Egypt/14051-NAMRU3/2005.
substitution observed also in the A/H5N1 strains from Gaza and Israel.
substitution found also in the A/H5N1 strain A/ck/Crimea/04/2005.